04.04.2016
- Analysts love looking into the future, particularly when it comes to big pharma’s prospect for growth and earnings. The industry experts of Morningstar see slowing patent losses...
10.03.2016
- France’s Sanofi Pasteur and Merck of the US have announced plans to end their 50:50 European vaccines joint venture, Sanofi Pasteur MSD, by the end of 2016 and manage their vaccine...
24.02.2016
- Austrian biotech firm OncoQR ML has cleared an important hurdle toward producing a vaccine against pancreatic cancer. In a preclinical trial of what it termed “a highly relevant...
05.02.2016
- Immediately following the decision by the World Health Organization (WHO) to declare a global emergency over the Zika virus' suspected link to birth defects, Sanofi Pasteur, the...
27.01.2016
- Geneva, Switzerland-based GAVI (Global Alliance for Vaccines and Immunization), a public-private partnership, and Merck Sharp & Dohme (MSD), known in the US as Merck & Co, have...
15.12.2015
- Mexico has granted marketing authorization to Sanofi Pasteur for its dengue vaccine, Dengvaxia. The vaccine is the world’s first to be approved for preventing the disease which is...
06.11.2015
- GlaxoSmithKline (GSK) is expecting to file 20 new drugs by 2020, with another 20 to follow in the following five years. In a presentation to investors in New York, CEO Andrew Witty...
22.09.2015
- Bavarian Nordic, a Danish biotechnology company specializing in research, development and manufacture of active cancer immunotherapies and vaccines for infectious diseases, has...
